These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3401284)

  • 1. Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients.
    Niort G; Bulgarelli A; Cassader M; Pagano G
    Atherosclerosis; 1988 Jun; 71(2-3):113-9. PubMed ID: 3401284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood rheology changes during bezafibrate treatment.
    Caimi G; Francavilla G; Romano A; Catania A; Santonocito G; Sarno A
    Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a slow release formulation of bezafibrate on lipids, glucose homeostasis, platelets and fibrinogen in type II diabetics: a pilot study.
    Mathur S; Barradas MA; Mikhailidis DP; Dandona P
    Diabetes Res; 1990 Jul; 14(3):133-8. PubMed ID: 2132185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia.
    Pazzucconi F; Mannucci L; Mussoni L; Gianfranceschi G; Maderna P; Werba P; Franceschini G; Sirtori CR; Tremoli E
    Eur J Clin Pharmacol; 1992; 43(3):219-23. PubMed ID: 1425883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of bezafibrate in the diet of hypertensive patients with dyslipidemia and hyperfibrinogenemia].
    Vázquez-Chávez C; Salinas-Orozco S; Gómez-Díaz RA; Rosso-Juárez MM; Moreno-Vázquez K; Nissen-Torres T; Argüero-Sánchez R
    Rev Invest Clin; 1998; 50(6):491-6. PubMed ID: 10070221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of bezafibrate and acipimox on the lipid pattern and plasma fibrinogen in hyperlipidaemic type 2 (non-insulin-dependent) diabetic patients.
    Niort G; Cassader M; Gambino R; Pagano G
    Diabete Metab; 1992; 18(3):221-8. PubMed ID: 1397477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary study on erythrocyte filterability and other hemorrheological parameters in arteriosclerotic vascular disease].
    Pernigotti L; Neirotti M
    Ric Clin Lab; 1983; 13 Suppl 3():423-6. PubMed ID: 6673024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human platelet fibrinogen: a protein different from plasma fibrinogen.
    Soria J; Soria C; Samama M; Poirot E; Kling C
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():15-7. PubMed ID: 796805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
    Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
    Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipact of bezafibrate treatment in patients with hyperfibrinogenemia and ST-elevation acute myocardial infarction: a randomized clinical trial.
    Madrid-Miller A; Moreno-Ruiz LA; Borrayo-Sánchez G; Almeida-Gutiérrez E; Martínez-Gómez DF; Jáuregui-Aguilar R
    Cir Cir; 2010; 78(3):229-37. PubMed ID: 20642906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
    Kaplan KL; Nossel HL; Drillings M; Lesznik G
    Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy.
    de Man FH; Nieuwland R; van der Laarse A; Romijn F; Smelt AH; Gevers Leuven JA; Sturk A
    Atherosclerosis; 2000 Oct; 152(2):407-14. PubMed ID: 10998469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bezafibrate on lipids, lipoproteins, apolipoproteins and platelet aggregation in hypertriglyceridemic patients.
    Waysbort J; Schwartz S; Brunner D
    Arzneimittelforschung; 1994 Nov; 44(11):1217-22. PubMed ID: 7893284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study.
    Tanne D; Benderly M; Goldbourt U; Boyko V; Brunner D; Graff E; Reicher-Reiss H; Shotan A; Mandelzweig L; Behar S;
    Am J Med; 2001 Oct; 111(6):457-63. PubMed ID: 11690571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
    Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN
    Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinopeptide A excretion in urine in patients with atherosclerotic artery disease.
    Gallino A; Haeberli A; Straub PW
    Thromb Res; 1985 Jul; 39(2):237-44. PubMed ID: 4024054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibrinolytic system and coagulation during bezafibrate treatment of hypertriglyceridemia.
    Almér LO; Kjellström T
    Atherosclerosis; 1986 Jul; 61(1):81-5. PubMed ID: 3524588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
    Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
    Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentration of platelet-specific proteins and fibrinopeptide A in patients with artificial heart valves.
    Dudczak R; Niessner H; Thaler E; Lechner K; Kletter K; Frischauf H; Domanig E; Aicher H
    Haemostasis; 1981; 10(4):186-94. PubMed ID: 6454613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.